The Data Layer Problem Life Sciences Can’t Ignore
Applications have gone serverless, stateless, and intelligent. But across much of the life sciences industry, the data infrastructure underneath them hasn’t kept pace. Legacy databases remain monolithic, expensive to maintain, and painful to migrate. That disconnect is becoming harder to ignore as organizations push toward AI-powered workflows, automated pipelines, and real-time analytics.
Aniebiet Abasi Akpan recently attended the Databricks Data + AI event, where several announcements underscored just how fast this shift is moving in the broader tech landscape. While Databricks has historically seen stronger adoption in entertainment, business, and technology, the trends on display have direct implications for the scientific organizations BioTeam works with every day.
Compute-Storage Separation Goes Mainstream
One of the headline announcements was Lakebase, a fully managed serverless Postgres offering built on compute-storage separation with git-based maintainability. It’s the latest signal that the industry is moving decisively away from tightly coupled database architectures.
For life sciences teams still running on-prem or legacy database infrastructure, this trend matters regardless of which vendor you’re evaluating. The ability to scale compute independently from storage, reduce operational overhead, and version-control your data layer is becoming table stakes, not a nice-to-have.
Semantic Layers Are the Bottleneck for AI Value
A recurring theme at the event was the critical role of semantic layers, the abstraction that translates raw data into meaningful, queryable context for downstream tools and users. AI agents and AI-powered dashboards are only as useful as the data models underneath them. Skip the semantic layer, and you’re deploying intelligence on top of data that doesn’t actually make sense at the research or business level.
This is something BioTeam sees constantly across our client engagements. Making data AI-ready is not a model-layer problem. It starts with how data is structured, governed, and made interpretable well before any agent or dashboard touches it.
Agentic AI Needs Governance Built In
The event also showcased platforms for building enterprise-grade AI agents using supervisor-agent delegation patterns, in which a primary agent interacts with end users and routes tasks to specialized sub-agents and to MCP (Model Context Protocol) integrations. The emphasis was on governance: auditability, controllability, and organizational guardrails baked into the architecture from the start.
For regulated industries like pharma and biotech, this is the piece that matters most. Agentic AI is moving fast, but adoption in life sciences will hinge on whether governance frameworks can keep up. Organizations that start thinking about agent governance now, rather than retrofitting it later, will be better positioned as these tools mature.
Life Sciences Should Be Paying Closer Attention
Platforms like Databricks and Snowflake are tackling many of the same infrastructure challenges, but with different adoption patterns across industries. Life sciences have largely gravitated toward Snowflake, and whether that’s driven by ecosystem maturity, compliance posture, existing integrations, or inertia is worth examining. As serverless data infrastructure, semantic modeling, and governed agentic AI continue to evolve, it’s a good time for life sciences leaders to reassess their platform assumptions.
Have Questions? Feel free to reach out
Photo taken by Wisdom Akpan at DataBricks Boston, April 2026
